
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy
Jianning Zhai, Huarong Chen, Chi Chun Wong, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 445-462
Open Access | Times Cited: 59
Jianning Zhai, Huarong Chen, Chi Chun Wong, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 445-462
Open Access | Times Cited: 59
Showing 1-25 of 59 citing articles:
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Qing Li, Shan Geng, Hao Luo, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 36
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Wnt/β-catenin signalling, epithelial-mesenchymal transition and crosslink signalling in colorectal cancer cells
Luanbiao Sun, Jianpeng Xing, Xuanpeng Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116685-116685
Open Access | Times Cited: 18
Luanbiao Sun, Jianpeng Xing, Xuanpeng Zhou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116685-116685
Open Access | Times Cited: 18
Single-Cell Chromatin Accessibility Analysis Reveals the Epigenetic Basis and Signature Transcription Factors for the Molecular Subtypes of Colorectal Cancers
Zhenyu Liu, Yuqiong Hu, Haoling Xie, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1082-1105
Closed Access | Times Cited: 10
Zhenyu Liu, Yuqiong Hu, Haoling Xie, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1082-1105
Closed Access | Times Cited: 10
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer
Mingming Sun, Yinzi Yue, Xiaopeng Wang, et al.
Experimental Cell Research (2024) Vol. 437, Iss. 1, pp. 113994-113994
Open Access | Times Cited: 8
Mingming Sun, Yinzi Yue, Xiaopeng Wang, et al.
Experimental Cell Research (2024) Vol. 437, Iss. 1, pp. 113994-113994
Open Access | Times Cited: 8
Epigenetic regulation of tumor immunity
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
Lizhi Pang, Fei Zhou, Yang Liu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
RNA modifications in cancer
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Han Wu, Shi Chen, Xiang Li, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit‐and‐run” paradigm
Bing He, Yiyang Hu, Yu-Yun Wu, et al.
Cancer Communications (2025)
Open Access | Times Cited: 1
Bing He, Yiyang Hu, Yu-Yun Wu, et al.
Cancer Communications (2025)
Open Access | Times Cited: 1
Interplay of m6A RNA methylation and gut microbiota in modulating gut injury
Haixia Wang, Juanjuan Han, Xinan Zhang
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Haixia Wang, Juanjuan Han, Xinan Zhang
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?
Hilmi Yazıcı, Ayse Eren Kayaci, Halil İbrahim Sevindi, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Hilmi Yazıcı, Ayse Eren Kayaci, Halil İbrahim Sevindi, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer
Daqin Suo, Xiaoling Gao, Qingyun Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Daqin Suo, Xiaoling Gao, Qingyun Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Breaking the Barrier: Epigenetic Strategies to Combat Platinum Resistance in Colorectal Cancer
Shiwen Luo, Yue Ming, Dequan Wang, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101152-101152
Open Access | Times Cited: 5
Shiwen Luo, Yue Ming, Dequan Wang, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101152-101152
Open Access | Times Cited: 5
Enhancing immunotherapy efficacy in colorectal cancer: targeting the FGR-AKT-SP1-DKK1 axis with DCC-2036 (Rebastinib)
Xiguang Chen, Qiting Zeng, Liyang Yin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Xiguang Chen, Qiting Zeng, Liyang Yin, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms
Miaochun Fang, Liwen Ye, Yue Zhu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 157-157
Open Access
Miaochun Fang, Liwen Ye, Yue Zhu, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 157-157
Open Access
Targeted editing of CCL5 with CRISPR-Cas9 nanoparticles enhances breast cancer immunotherapy
Yan Wei, Shuo Wang, Li Zhu, et al.
APOPTOSIS (2025)
Open Access
Yan Wei, Shuo Wang, Li Zhu, et al.
APOPTOSIS (2025)
Open Access
m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications
Xin Tong, Shifeng Qiao, Zhe Dong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Xin Tong, Shifeng Qiao, Zhe Dong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Targeting CHEK1: Ginsenosides-Rh2 and Cu2O@G-Rh2 nanoparticles in thyroid cancer
Lidong Wang, Xin Wu, Xinlu Wang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Lidong Wang, Xin Wu, Xinlu Wang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Identification and Validation of a m6A ‐Related Long Noncoding RNA Prognostic Model in Colorectal Cancer
Jiang Peng, Mon‐Li Chu, Yu Liang
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access
Jiang Peng, Mon‐Li Chu, Yu Liang
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 2
Open Access